Early Fine Motor Impairment and Behavioral Dysfunction in (Thy-1)-h[A30P] Alpha-synuclein Mice

Overview

Journal Brain Behav

Specialty Psychology

Date 2018 Mar 16

PMID 29541535

Citations 17

Authors

Sara Ekmark-Lewen

Veronica Lindstrom

Astrid Gumucio

Elisabeth Ihse

Anish Behere

Philipp J Kahle

Eva Nordstrom

Maria Eriksson

Anna Erlandsson

Joakim Bergstrom

Martin Ingelsson

Affiliations

Soon will be listed here.

Abstract

Introduction: Intraneuronal inclusions of alpha-synuclein are commonly found in the brain of patients with Parkinson's disease and other α-synucleinopathies. The correlation between alpha-synuclein pathology and symptoms has been studied in various animal models. In (Thy-1)-h[A30P] alpha-synuclein transgenic mice, behavioral and motor abnormalities were reported from 12 and 15 months, respectively. The aim of this study was to investigate whether these mice also display symptoms at earlier time points.

Methods: We analyzed gait deficits, locomotion, and behavioral profiles in (Thy-1)-h[A30P] alpha-synuclein and control mice at 2, 8, and 11 months of age. In addition, inflammatory markers, levels of alpha-synuclein oligomers, and tyrosine hydroxylase reactivity were studied.

Results: Already at 2 months of age, transgenic mice displayed fine motor impairments in the challenging beam test that progressively increased up to 11 months of age. At 8 months, transgenic mice showed a decreased general activity with increased risk-taking behavior in the multivariate concentric square field test. Neuropathological analyses of 8- and 11-month-old mice revealed accumulation of oligomeric alpha-synuclein in neuronal cell bodies. In addition, a decreased presence of tyrosine hydroxylase suggests a dysregulation of the dopaminergic system in the transgenic mice, which in turn may explain some of the motor impairments observed in this mouse model.

Conclusions: Taken together, our results show that the (Thy-1)-h[A30P] alpha-synuclein transgenic mouse model displays early Parkinson's disease-related symptoms with a concomitant downregulation of the dopaminergic system. Thus, this should be an appropriate model to study early phenotypes of alpha-synucleinopathies.

Citing Articles

Behavioral analysis of motor and non-motor impairment in rodent models of Parkinson's disease.

Sheta R, Berard M, Musiol D, Martinez-Drudis L, Oueslati A Front Aging Neurosci. 2025; 16:1464706.

PMID: 39763579 PMC: 11701160. DOI: 10.3389/fnagi.2024.1464706.

Application of serum peptidomics for Parkinson's disease in SNCA-A30P mice.

Yin Z, Xu G, Qi Y, Tan D, Chen E, Ding X Heliyon. 2023; 9(12):e21125.

PMID: 38125428 PMC: 10730432. DOI: 10.1016/j.heliyon.2023.e21125.

Reduction of brain stem pathology and transient amelioration of early cognitive symptoms in transgenic mice treated with a monoclonal antibody against α-synuclein oligomers/protofibrils.

Ekmark-Lewen S, Aniszewska A, Molisak A, Gumucio A, Lindstrom V, Kahle P Aging Brain. 2023; 4:100086.

PMID: 37559953 PMC: 10407822. DOI: 10.1016/j.nbas.2023.100086.

Animal models of Parkinson's disease: bridging the gap between disease hallmarks and research questions.

Dovonou A, Bolduc C, Soto Linan V, Gora C, Peralta Iii M, Levesque M Transl Neurodegener. 2023; 12(1):36.

PMID: 37468944 PMC: 10354932. DOI: 10.1186/s40035-023-00368-8.

miR-101a-3p Impairs Synaptic Plasticity and Contributes to Synucleinopathy.

Xylaki M, Paiva I, Al-Azzani M, Gerhardt E, Jain G, Islam M J Parkinsons Dis. 2023; 13(2):179-196.

PMID: 36744345 PMC: 10041420. DOI: 10.3233/JPD-225055.

References

Fahn S, Libsch L, Cutler R . Monoamines in the human neostriatum: topographic distribution in normals and in Parkinson's disease and their role in akinesia, rigidity, chorea, and tremor. J Neurol Sci. 1971; 14(4):427-55. DOI: 10.1016/0022-510x(71)90178-x. View

Spillantini M, Schmidt M, Lee V, Trojanowski J, Jakes R, Goedert M . Alpha-synuclein in Lewy bodies. Nature. 1997; 388(6645):839-40. DOI: 10.1038/42166. View

Kahle P, Neumann M, Ozmen L, Muller V, Jacobsen H, Schindzielorz A . Subcellular localization of wild-type and Parkinson's disease-associated mutant alpha -synuclein in human and transgenic mouse brain. J Neurosci. 2000; 20(17):6365-73. PMC: 6772969. View

Cover T, Blanke S . Helicobacter pylori VacA, a paradigm for toxin multifunctionality. Nat Rev Microbiol. 2005; 3(4):320-32. DOI: 10.1038/nrmicro1095. View

Rockenstein E, Mallory M, Hashimoto M, Song D, Shults C, Lang I . Differential neuropathological alterations in transgenic mice expressing alpha-synuclein from the platelet-derived growth factor and Thy-1 promoters. J Neurosci Res. 2002; 68(5):568-78. DOI: 10.1002/jnr.10231. View

Lindstrom V, Ihse E, Fagerqvist T, Bergstrom J, Nordstrom E, Moller C . Immunotherapy targeting α-synuclein, with relevance for future treatment of Parkinson's disease and other Lewy body disorders. Immunotherapy. 2014; 6(2):141-53. DOI: 10.2217/imt.13.162. View

Lee V, Trojanowski J . Mechanisms of Parkinson's disease linked to pathological alpha-synuclein: new targets for drug discovery. Neuron. 2006; 52(1):33-8. DOI: 10.1016/j.neuron.2006.09.026. View

Crusio W, Schwegler H, Brust I, van Abeelen J . Genetic selection for novelty-induced rearing behavior in mice produces changes in hippocampal mossy fiber distributions. J Neurogenet. 1989; 5(1):87-93. DOI: 10.3109/01677068909167267. View

Fernagut P, Hutson C, Fleming S, Tetreaut N, Salcedo J, Masliah E . Behavioral and histopathological consequences of paraquat intoxication in mice: effects of alpha-synuclein over-expression. Synapse. 2007; 61(12):991-1001. PMC: 3097512. DOI: 10.1002/syn.20456. View

10.

Frasier M, WALZER M, McCarthy L, Magnuson D, Lee J, Haas C . Tau phosphorylation increases in symptomatic mice overexpressing A30P alpha-synuclein. Exp Neurol. 2005; 192(2):274-87. DOI: 10.1016/j.expneurol.2004.07.016. View

11.

Winner B, Jappelli R, Maji S, Desplats P, Boyer L, Aigner S . In vivo demonstration that alpha-synuclein oligomers are toxic. Proc Natl Acad Sci U S A. 2011; 108(10):4194-9. PMC: 3053976. DOI: 10.1073/pnas.1100976108. View

12.

Wilms H, Rosenstiel P, Romero-Ramos M, Arlt A, Schafer H, Seegert D . Suppression of MAP kinases inhibits microglial activation and attenuates neuronal cell death induced by alpha-synuclein protofibrils. Int J Immunopathol Pharmacol. 2010; 22(4):897-909. DOI: 10.1177/039463200902200405. View

13.

Altschuler E . Gastric Helicobacter pylori infection as a cause of idiopathic Parkinson disease and non-arteric anterior optic ischemic neuropathy. Med Hypotheses. 1996; 47(5):413-4. DOI: 10.1016/s0306-9877(96)90223-6. View

14.

Fagerqvist T, Lindstrom V, Nordstrom E, Lord A, Tucker S, Su X . Monoclonal antibodies selective for α-synuclein oligomers/protofibrils recognize brain pathology in Lewy body disorders and α-synuclein transgenic mice with the disease-causing A30P mutation. J Neurochem. 2013; 126(1):131-44. DOI: 10.1111/jnc.12175. View

15.

Ekmark-Lewen S, Lindstrom V, Gumucio A, Ihse E, Behere A, Kahle P . Early fine motor impairment and behavioral dysfunction in (Thy-1)-h[A30P] alpha-synuclein mice. Brain Behav. 2018; 8(3):e00915. PMC: 5840441. DOI: 10.1002/brb3.915. View

16.

Fleming S, Salcedo J, Hutson C, Rockenstein E, Masliah E, Levine M . Behavioral effects of dopaminergic agonists in transgenic mice overexpressing human wildtype alpha-synuclein. Neuroscience. 2006; 142(4):1245-53. PMC: 3108485. DOI: 10.1016/j.neuroscience.2006.07.005. View

17.

Alvarez-Arellano L, Maldonado-Bernal C . Helicobacter pylori and neurological diseases: Married by the laws of inflammation. World J Gastrointest Pathophysiol. 2014; 5(4):400-4. PMC: 4231504. DOI: 10.4291/wjgp.v5.i4.400. View

18.

Sidhu A, Wersinger C, Vernier P . Does alpha-synuclein modulate dopaminergic synaptic content and tone at the synapse?. FASEB J. 2004; 18(6):637-47. DOI: 10.1096/fj.03-1112rev. View

19.

Ekmark-Lewen S, Flygt J, Fridgeirsdottir G, Kiwanuka O, Hanell A, Meyerson B . Diffuse traumatic axonal injury in mice induces complex behavioural alterations that are normalized by neutralization of interleukin-1β. Eur J Neurosci. 2016; 43(8):1016-33. DOI: 10.1111/ejn.13190. View

20.

Danzer K, Haasen D, Karow A, Moussaud S, Habeck M, Giese A . Different species of alpha-synuclein oligomers induce calcium influx and seeding. J Neurosci. 2007; 27(34):9220-32. PMC: 6672196. DOI: 10.1523/JNEUROSCI.2617-07.2007. View